AU4988697A - Monophosphate prodrugs of beta-l-fd4c and beta-l-fddc as potent antiviral agents - Google Patents
Monophosphate prodrugs of beta-l-fd4c and beta-l-fddc as potent antiviral agentsInfo
- Publication number
- AU4988697A AU4988697A AU49886/97A AU4988697A AU4988697A AU 4988697 A AU4988697 A AU 4988697A AU 49886/97 A AU49886/97 A AU 49886/97A AU 4988697 A AU4988697 A AU 4988697A AU 4988697 A AU4988697 A AU 4988697A
- Authority
- AU
- Australia
- Prior art keywords
- beta
- fd4c
- fddc
- antiviral agents
- potent antiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HSBKFSPNDWWPSL-VDTYLAMSSA-N 4-amino-5-fluoro-1-[(2s,5r)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one Chemical compound C1=C(F)C(N)=NC(=O)N1[C@@H]1C=C[C@H](CO)O1 HSBKFSPNDWWPSL-VDTYLAMSSA-N 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000004712 monophosphates Chemical class 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73615696A | 1996-10-24 | 1996-10-24 | |
| US08736156 | 1996-10-24 | ||
| PCT/US1997/018860 WO1998017281A1 (en) | 1996-10-24 | 1997-10-23 | MONOPHOSPHATE PRODRUGS OF β-L-FD4C AND β-L-FddC AS POTENT ANTIVIRAL AGENTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4988697A true AU4988697A (en) | 1998-05-15 |
Family
ID=24958728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU49886/97A Abandoned AU4988697A (en) | 1996-10-24 | 1997-10-23 | Monophosphate prodrugs of beta-l-fd4c and beta-l-fddc as potent antiviral agents |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU4988697A (en) |
| WO (1) | WO1998017281A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1210354A1 (en) * | 1999-09-08 | 2002-06-05 | Metabasis Therapeutics, Inc. | Prodrugs for liver specific drug delivery |
| EP1803730A1 (en) | 2000-04-12 | 2007-07-04 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| AU2001282856A1 (en) | 2000-06-15 | 2001-12-24 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
| CN100560073C (en) | 2001-12-14 | 2009-11-18 | 法玛塞特公司 | N4-acylcytidine nucleosides for the treatment of viral infections |
| AU2002364586A1 (en) | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| WO2004043402A2 (en) * | 2002-11-12 | 2004-05-27 | Pharmasset, Inc. | Modified nucleosides as antiviral agents |
| US7892563B2 (en) | 2003-05-20 | 2011-02-22 | Wyeth Holdings Corporation | Methods for treatment of severe acute respiratory syndrome (SARS) |
| EA015860B1 (en) | 2005-10-13 | 2011-12-30 | Хьюман Дженом Сайенсиз, Инк. | Methods for treatment of autoimmune diseases using neutrokine-alpha antagonist |
| US8076303B2 (en) | 2005-12-13 | 2011-12-13 | Spring Bank Pharmaceuticals, Inc. | Nucleotide and oligonucleotide prodrugs |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| US8729058B2 (en) | 2009-10-27 | 2014-05-20 | Michael Zasloff | Methods and compositions for treating and preventing viral infections |
| WO2011066260A2 (en) | 2009-11-25 | 2011-06-03 | Michael Zasloff | Formulations comprising aminosterols |
| CN108239128B (en) * | 2016-12-23 | 2019-03-29 | 江苏奥赛康药业股份有限公司 | The preparation method of beta-nucleosides class compound |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW374087B (en) * | 1993-05-25 | 1999-11-11 | Univ Yale | L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents |
-
1997
- 1997-10-23 WO PCT/US1997/018860 patent/WO1998017281A1/en not_active Ceased
- 1997-10-23 AU AU49886/97A patent/AU4988697A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998017281A1 (en) | 1998-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL329177A1 (en) | Derivatives of azahexane ehxibiting antiviral activity | |
| AU3612895A (en) | Purine and guanine compounds as inhibitors of pnp | |
| AU4125099A (en) | Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine | |
| IL122642A0 (en) | Substituted purine derivatives processes for their preparation their use and compositions comprising them | |
| AU4988697A (en) | Monophosphate prodrugs of beta-l-fd4c and beta-l-fddc as potent antiviral agents | |
| HU9601524D0 (en) | Prodrugs of paklytaxel-derivatives | |
| AU4772493A (en) | Sulfo-derivatives of adenosine | |
| AU4384297A (en) | Antiviral compositions | |
| AP9600870A0 (en) | Preparation of purines | |
| SG44742A1 (en) | Intermediates and process for the preparation of an antiviral agent | |
| AU6135896A (en) | Antiviral agents | |
| AU5703198A (en) | Extracts of salvia species having antiviral activity | |
| AU1595997A (en) | Thienoxazinone derivatives useful as antiviral agents | |
| AU4817599A (en) | Antiviral alkyl substituted purine derivatives and their preparation | |
| AU4377397A (en) | Novel therapeutically active adenosine derivatives | |
| AU9261198A (en) | Antiviral agent | |
| AU4834096A (en) | Compositions having antiviral properties and preparation process | |
| AU4347596A (en) | Thienoxazinone derivatives useful as antiviral agents | |
| AU5511196A (en) | Acyclovir derivatives as antiviral agents | |
| AU2439697A (en) | Prodrugs of acyclovir | |
| PL316985A1 (en) | Derivatives of adenosine | |
| AU7140296A (en) | Purine and guanine derivatives as pnp inhibitors | |
| AU1029295A (en) | Production of nucleoside analogues | |
| AU6746996A (en) | Antiviral compositions and methods | |
| AU3395295A (en) | Alkaloids and their antiviral agents |